Prognostic significance of vessel architecture and vascular stability in non-small cell lung cancer

Lung Cancer

Volumn 55, Issue 1, 2007, Pages 53-60

  Reinmuth, Niels ^a,b   Piegelbrock, Elisabeth ^a   Raedel, Miriam ^a   Fehrmann, Nicole ^a   Hintelmann, Heike ^a   Wagner, Ruth ^a   Berdel, Wolfgang E ^a   Thomas, Michael ^b   Freitag, Lutz ^c   Mesters, Rolf M ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Clinic for Pulmonary Diseases   (Germany)

Author keywords

Angiogenesis; Angiopoietins; Coopted vessels; Pericytes; Vascular stability; VEGF

Indexed keywords

ANGIOPOIETIN 1; VASCULOTROPIN;

ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG BLOOD VESSEL; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SAMPLE; STATISTICAL ANALYSIS;

BLOOD VESSELS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; PROGNOSIS; PULMONARY CIRCULATION;

EID: 33845966075     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.09.025     Document Type: Article

References (28)

1. Reinmuth N., Liu W., Jung Y.D., et al. Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival. FASEB J 15 (2001) 1239-1241
2. Kojima H., Shijubo N., and Abe S. Thymidine phosphorylase and vascular endothelial growth factor in patients with stage I lung adenocarcinoma. Cancer 94 (2002) 1083-1093
3. Giatromanolaki A., Koukourakis M., O'Byrne K., et al. Prognostic value of angiogenesis in operable non-small cell lung cancer. J Pathol 179 (1996) 80-88
4. Pastorino U., Andreola S., Tagliabue E., et al. Immunocytochemical markers in stage I lung cancer: relevance to prognosis. J Clin Oncol 15 (1997) 2858-2865
5. Holash J., Maisonpierre P.C., Compton D., et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284 (1999) 1994-1998
6. Pezzella F., Pastorino U., Tagliabue E., et al. Non-small cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol 151 (1997) 1417-1423
7. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 3 (1992) 65-71
8. Jain R.K. Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med 7 (2001) 987-989
9. Korff T., Kimmina S., Martiny-Baron G., et al. Blood vessel maturation in a three-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness. FASEB J 15 (2001) 447-457
10. Yang A.D., Bauer T.W., Camp E.R., et al. Improving delivery of antineoplastic agents with anti-vascular endothelial growth factor therapy. Cancer 103 (2005) 1561-1570
11. Tait C.R., and Jones P.F. Angiopoietins in tumors: the angiogenic swith. J Pathol 204 (2004) 1-10
12. Hayes A.J., Huang W.Q., Mallah J., et al. Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells. Microvasc Res 58 (1999) 224-237
13. Suri C., McClain J., Thurston G., et al. Increased vascularization in mice overexpressing angiopoietin-1. Science 282 (1998) 468-471
14. Ahmad S.A., Liu W., Jung Y.D., et al. Differential expression of angiopoietin-1 and angiopoietin-2 in colon carcinoma. A possible mechanism for the initiation of angiogenesis. Cancer 92 (2001) 1138-1143
15. Chae J.K., Kim I., Lim S.T., et al. Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscler Thromb Vasc Biol 20 (2000) 2573-2578
16. Thurston G., Rudge J.S., Ioffe E., et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6 (2000) 460-463
17. Maisonpierre P.C., Suri C., Jones P.F., et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277 (1997) 55-60
18. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
19. Shaheen R.M., Davis D.W., Liu W., et al. Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis. Cancer Res 59 (1999) 5412-5416
20. Bieker R., Padro T., Kramer J., et al. Overexpression of basic fibroblast growth factor and autocrine stimulation in acute myeloid leukemia. Cancer Res 63 (2003) 7241-7246
21. Kreuter M., Bieker R., Bielack S.S., et al. Prognostic relevance of increased angiogenesis in osteosarcoma. Clin Cancer Res 10 (2004) 8531-8537
22. Reinmuth N., Fan F., Liu W., et al. Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer. Lab Invest 82 (2002) 1377-1389
23. Reinmuth N., Liu W., Ahmad S.A., et al. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice. Cancer Res 63 (2003) 2079-2087
24. Eberhard A., Kahlert S., Goede V., et al. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res 60 (2000) 1388-1393
25. Padro T., Bieker R., Ruiz S., et al. Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia. Leukemia 16 (2002) 1302-1310
26. Offersen B.V., Pfeiffer P., Hamilton-Dutoit S., et al. Patterns of angiogenesis in non-small cell lung carcinoma. Cancer 91 (2001) 1500-1509
27. Milne E.N., Noonan C.D., Margulis A.R., et al. Vascular supply of pulmonary metastases. Experimental study in rats. Invest Radiol 4 (1969) 215-229
28. Tanaka F., Ishikawa S., Yanagihara K., et al. Expression of angiopoietins and its clinical significance in non-small cell lung cancer. Cancer Res 62 (2002) 7124-7129